RxDoctor Payments Data

Daniel Gans, MD

Vascular & Interventional Radiology · Edgewood, KYNPI 1508122029

Payments from drug & device makers

What this record shows

13 manufacturers reported payments, led by Angiodynamics, Inc. at 57.6% of the total. 2025 is the largest year on record at $2,887, more than ten times the $176 reported in 2019.

$7,679in general payments, 2019–2025

Across 75 payments — averaging $102.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Angiodynamics, Inc.$4K
  • W. L. Gore & Associates, Inc.$1K
  • Penumbra, Inc.$557
  • Silk Road Medical, Inc.$369
  • Medtronic$313
  • Surmodics, Inc.$266
  • plus $603 from 7 others
$55,440in research payments, 2019–2025

Across 4 payments — averaging $13,860 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Angiodynamics, Inc.$55K

What the payments were for

  • Travel & lodging$3,08240%
  • Food & beverage$4,59760%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,679 in reported general payments places this provider in the 80th percentile of 41 vascular & interventional radiology providers in Kentucky.

See all vascular & interventional radiology providers in Kentucky

Medicare billing

Part B allowed, 2024
$161,234
Medicare patients
1,524
Services billed
2,320

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium22$880
ClopidogrelClopidogrel Bisulfate45$543
Atorvastatin Calcium19$91

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Edgewood

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →